Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.45
23.09.20
-
04.11.21
-47.51%
15.07.21

Probably not worthwhile Investment
buy
Horizon Pharma plc

Start price
Target price
Perf. (%)
€71.00
23.09.20
-
26.10.20
-7.82%
26.10.20

Could be very worthwhile Investment >20% year
Inovio Pharma

Start price
Target price
Perf. (%)
€13.60
23.09.20
-
26.10.20
-31.99%
26.10.20

Risky Investment
buy
Orange S.A.

Start price
Target price
Perf. (%)
€9.30
23.09.20
€15.00
04.11.21
5.51%
11.02.21

Could be worthwhile Investment >10% per year
High dividend yield expected
Revenue growth >5% per year expected
Small cyclical dependencies
buy
Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€9.21
23.09.20
€14.00
04.11.21
692.62%
05.11.21

Fair valuation
Some uniques
Future proof or reliable business model
buy
Gamestop Corp.

Start price
Target price
Perf. (%)
€2.26
23.09.20
-
04.11.21
1984.35%
05.11.21

Could be worthwhile Investment >10% per year
Oz Minerals Ltd

Start price
Target price
Perf. (%)
€8.55
23.09.20
-
04.11.21
77.16%
05.11.21

Could be worthwhile Investment >10% per year
buy
Evotec SE

Start price
Target price
Perf. (%)
€23.43
23.09.20
€36.00
04.11.21
58.26%
21.06.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Fair valuation
High Investments for future growth
Tesla Inc

Start price
Target price
Perf. (%)
€115.42
23.09.20
-
04.11.21
22.37%
23.11.20

Very capable Management
Workhorse Group Inc

Start price
Target price
Perf. (%)
€22.01
23.09.20
-
04.11.21
-36.44%
01.03.21

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Low dividend yield expected
negative Cash Flow expected
B2gold Corp.

Start price
Target price
Perf. (%)
€5.52
23.09.20
-
04.11.21
-6.45%
12.11.20

Could be very worthwhile Investment >20% year
Below average Marketposition
Very high cyclical dependencies
Unknown brand
buy
Accell Group NV

Start price
Target price
Perf. (%)
€24.15
22.09.20
€50.00
04.11.21
55.90%
05.11.21

Could be worthwhile Investment >10% per year
buy
Bio-Rad Labs Inc. A

Start price
Target price
Perf. (%)
€440.00
22.09.20
-
04.11.21
47.73%
05.11.21

AstraZeneca plc

Start price
Target price
Perf. (%)
€94.00
22.09.20
€78.00
04.11.21
-0.76%
07.06.21

Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.90
22.09.20
-
04.11.21
-49.70%
05.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Gogold Resources Inc.

Start price
Target price
Perf. (%)
€0.95
22.09.20
-
04.11.21
151.84%
05.11.21

Could be very worthwhile Investment >20% year
Chalice Gold Mines Ltd

Start price
Target price
Perf. (%)
€1.41
22.09.20
-
04.11.21
210.89%
05.11.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
buy
Fiserv Inc.

Start price
Target price
Perf. (%)
€85.20
22.09.20
-
04.11.21
10.22%
06.01.21

EBIT growth >5% per year expected
Revenue growth >5% per year expected
Yoc AG

Start price
Target price
Perf. (%)
€5.25
22.09.20
-
04.11.21
98.10%
05.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Salesforce.com

Start price
Target price
Perf. (%)
€207.85
21.09.20
-
04.11.21
-6.17%
01.12.20

Could be worthwhile Investment >10% per year
Very capable Management
Market Leader or Top 3
Very Future proof/growth oriented business model
buy
Inpixon

Start price
Target price
Perf. (%)
€66.00
21.09.20
€150.00
05.10.20
18.18%
05.10.20

Could be worthwhile Investment >10% per year
buy
Hornbach Baumarkt AG

Start price
Target price
Perf. (%)
€39.00
21.09.20
-
04.11.21
-12.95%
24.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
buy
Smith & Wesson Brands Inc.

Start price
Target price
Perf. (%)
€12.61
21.09.20
-
04.11.21
5.92%
09.11.20

Agra Ventures Ltd.

Start price
Target price
Perf. (%)
€2.55
21.09.20
-
04.11.21
17.65%
21.11.20

Some uniques
Higher risks for its business
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€42.80
21.09.20
€50.00
04.11.21
-16.45%
05.11.21

Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Future proof or reliable business model
Increased challenges to pay loans and raise capital